Use of Cell Salvage Post-operatively in Infants to Decrease Use of Allogeneic Blood Product Transfusions

Completed · Not applicable

Conditions studied: Transfusion

In brief

Transfusion of washed intra-operative cell salvage post-operatively in the PCICU can be performed safely without increased risk of bleeding or release of inflammatory mediators. This will reduce the need for allogeneic blood products as well as crystalloid and colloid infusions and thus decrease the length of ventilation and intensive care duration for these infants.

Key facts

Study ID

NCT01211366

Run by

University of Rochester

People needed

106

Starts

2010-10-01

Expected to finish

2011-12-01

Last updated by the study team

2012-02-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1. Weight < or = 20Kg;
• 2. Cardiac surgery with CPB at URMC;
• 3. informed consent

You may not qualify if…

• 1. weight > 21 Kg;
• inability to obtain consent;
• non-English speaking

Where it is running

• University of Rochester Medical Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.